As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor: Radnor, Pennsylvania Friday, January 10, 2025 ...